Artículos del autor

solaci

Coronary disease

These Are the Thrombosis Predictors for Absorb Bioresorbable Scaffolds

J Am Coll Cardiol Intv has recently published a special issue on bioresorbable scaffolds. Abbott's decision to...
solaci -
Peripheral vascular disease

A New Opportunity for Renal Denervation

Courtesy of dr. Carlos Fava. At first, renal denervation enjoyed a considerable boost because, according to early studies,...
solaci -
Institutional News

The work of a doctor in the catastrophe: anonymous testimony after the earthquakes in Mexico

The following is the anonymous testimony of a professional living in Mexico City who was directly affected...
solaci -
Institutional News

Letter from SOLACI President to Our Mexican Colleagues and Brothers

On behalf on the Latin American Society of Interventional Cardiology (SOLACI), today I extend my fraternal condolences...
solaci -
Institutional News

Dr. Juan Granada, New President and CEO of the Cardiovascular Research Foundation

The prestigious Colombian Interventional Cardiologist was appointed President and Chief Executive Officer (CEO) of the Cardiovascular Research...
solaci -
Coronary disease

Very Late Thrombosis in Bioresorbable Scaffolds

The presence of a metallic device interrupts normal laminar flow and creates an artery environment that favors...
solaci -
Structural heart disease

Conscious Sedation in TAVR: Is It Advisable?

The fundamental advantage offered by transcatheter aortic valve replacement (TAVR) has always been the fact that it...
solaci -
Chronic Ischemic cardiopathy

Introducing the number one enemy of PCI: diabetes

About 25% of patients with multivessel disease undergoing myocardial revascularization surgery or PCI have diabetes.   In this subgroup,...
solaci -